Your browser doesn't support javascript.
loading
Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.
Månsson, E; Paul, A; Löfgren, C; Ullberg, K; Paul, C; Eriksson, S; Albertioni, F.
Affiliation
  • Månsson E; Department of Medicine, Division of Clinical Pharmacology, Karolinska Hospital, Stockholm, Sweden.
Br J Haematol ; 114(3): 557-65, 2001 Sep.
Article in En | MEDLINE | ID: mdl-11552980
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Doxorubicin / Drug Resistance, Multiple / Cytarabine Limits: Humans Language: En Journal: Br J Haematol Year: 2001 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Promyelocytic, Acute / Doxorubicin / Drug Resistance, Multiple / Cytarabine Limits: Humans Language: En Journal: Br J Haematol Year: 2001 Document type: Article Affiliation country: Suecia Country of publication: Reino Unido